retatrutide nonalcoholic steatohepatitis nash trial fatty liver disease Current therapies and new developments in Nonalcoholic Fatty Liver Disease in

doi:10.1155/2017/5285810 174

There's now a pill but does it actually work

Effectiveness: In a study of 2,539 adults with obesity or overweight plus at least one weight-related medical condition (excluding diabetes), the average weight loss at 72 weeks was 15% with 5 mg weekly doses of tirzepatide, 19.5% with 10 mg doses, and almost 21% with 15 mg doses

Suppliers unable or unwilling to provide purity documentation should be avoided

[DOI] [PubMed] [Google Scholar] 217.Williams LT, Barnes K, Ball L, Ross LJ, Sladdin I, Mitchell LJ

Mounjaro r mest effektiv och ger i genomsnitt en viktnedgng p drygt 20 % p cirka ett r, jmfrt med Ozempic och Wegovy, som i genomsnitt visat en viktnedgng p knappt 15 % under drygt ett r